Embolic Protection Devices Market Size

Embolic Protection Devices Market Size

Embolic Protection Devices Market was worth USD 1.4 billion in 2022. Driven by the increasing number of cardiovascular diseases (CVDs) globally, the industry is estimated to witness over 8.5% CAGR between 2023 and 2032. According to the WHO, CVDs are the leading cause of death globally, accounting for 17.9 million deaths in 2022.

The growing number of patients suffering from cardiac problems is fueling the need for percutaneous coronary interventions and the subsequent rise in demand for interventional cardiology & peripheral vascular devices. As per CDC, coronary artery disease is the most prevalent kind of heart disease in the U.S. The growing prevalence of CAD is contributing to rising product demand. Additionally, embolic protection devices provide the most effective, evidence-based method for decreasing significant adverse cardiovascular events and periprocedural myocardial infarction during SVG procedures, which will favor their adoption through 2032.

Embolic Protection Devices Market Growth Drivers & Restraints

The market is poised to gain significant momentum attributed to the favorable reimbursement scenario across American nations and the introduction of new advanced embolic protection devices. However, the availability of cheaper alternatives to embolic protection devices may lead to sluggish growth. Besides, the high cost of these devices may adversely impact product adoption rate since healthcare professionals in developing nations prefer inexpensive medical equipment.